Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
218.6 INR | +0.57% | +3.06% | -23.76% |
Sales 2022 | 1.37B 16.45M | Sales 2023 | 2.39B 28.61M | Capitalization | 58.2B 697M |
---|---|---|---|---|---|
Net income 2022 | -2.03B -24.37M | Net income 2023 | -2.23B -26.67M | EV / Sales 2022 | 59.3 x |
Net Debt 2022 | 663M 7.95M | Net cash position 2023 | 3.87B 46.35M | EV / Sales 2023 | 22.8 x |
P/E ratio 2022 |
-38.4
x | P/E ratio 2023 |
-22.9
x | Employees | 407 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25.38% |
Latest transcript on Sun Pharma Advanced Research Company Limited
1 day | +0.57% | ||
1 week | +3.06% | ||
Current month | -5.88% | ||
1 month | -40.66% | ||
3 months | -39.36% | ||
6 months | -13.35% | ||
Current year | -23.76% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 14-04-23 | |
Chetan Rajpara
DFI | Director of Finance/CFO | - | 17-01-31 |
Chairman | 68 | 06-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 06-02-28 | |
Director/Board Member | 67 | 06-02-28 | |
Director/Board Member | 70 | 14-10-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +5.68% | - | |
0.00% | 34 M€ | +4.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 218.6 | +0.57% | 507 202 |
24-05-15 | 217.4 | -0.91% | 522,641 |
24-05-14 | 219.4 | +2.26% | 1,295,655 |
24-05-13 | 214.6 | -2.03% | 613,196 |
24-05-10 | 219 | +3.23% | 772,695 |
Delayed Quote NSE India S.E., May 16, 2024 at 06:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-23.76% | 846M | |
+35.01% | 709B | |
+30.91% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.40% | 239B | |
+9.40% | 211B | |
-4.34% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- SPARC Stock